Appendix 2—table 33. Antihypertensive User Cohort (Region=New York State) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| Region=NY Antihypertensive Users by BP: Unmatched | Region=NY Antihypertensive Users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 203,624 | 100.0% | 182,411 | 89.6% | 21,213 | 10.4% | 42,252 | 100.0% | 21,126 | 50.0% | 21,126 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 811 | 0.4% | 798 | 0.4% | 13 | 0.1% | <0.001 | 27 | 0.1% | 14 | 0.1% | 13 | 0.1% | 1.00 |
| 21-40 | 11,465 | 5.6% | 11,396 | 6.2% | 69 | 0.3% | 137 | 0.3% | 68 | 0.3% | 69 | 0.3% | ||
| 41-50 | 21,923 | 10.8% | 21,747 | 11.9% | 176 | 0.8% | 354 | 0.8% | 178 | 0.8% | 176 | 0.8% | ||
| 51-60 | 48,159 | 23.7% | 46,047 | 25.2% | 2,112 | 10.0% | 4,218 | 10.0% | 2,108 | 10.0% | 2,110 | 10.0% | ||
| 61-70 | 54,929 | 27.0% | 48,022 | 26.3% | 6,907 | 32.6% | 13,804 | 32.7% | 6,902 | 32.7% | 6,902 | 32.7% | ||
| 71-80 | 44,367 | 21.8% | 36,409 | 20.0% | 7,958 | 37.5% | 15,777 | 37.3% | 7,886 | 37.3% | 7,891 | 37.4% | ||
| ≥81 | 21,970 | 10.8% | 17,992 | 9.9% | 3,978 | 18.8% | 7,935 | 18.8% | 3,970 | 18.8% | 3,965 | 18.8% | ||
| Gender | ||||||||||||||
| Female | 120,465 | 59.2% | 101,190 | 55.5% | 19,275 | 90.9% | <0.001 | 38,380 | 90.8% | 19,190 | 90.8% | 19,190 | 90.8% | 1.00 |
| Male | 83,159 | 40.8% | 81,221 | 44.5% | 1,938 | 9.1% | 3,872 | 9.2% | 1,936 | 9.2% | 1,936 | 9.2% | ||
| Insurance | ||||||||||||||
| Commercial | 75,459 | 37.1% | 71,460 | 39.2% | 3,999 | 18.9% | <0.001 | 7,993 | 18.9% | 3,997 | 18.9% | 3,996 | 18.9% | 1.00 |
| Dual | 1,493 | 0.7% | 1,151 | 0.6% | 342 | 1.6% | 643 | 1.5% | 322 | 1.5% | 321 | 1.5% | ||
| Medicaid | 47,516 | 23.3% | 44,248 | 24.3% | 3,268 | 15.4% | 6,414 | 15.2% | 3,207 | 15.2% | 3,207 | 15.2% | ||
| Medicare | 79,156 | 38.9% | 65,552 | 35.9% | 13,604 | 64.1% | 27,202 | 64.4% | 13,600 | 64.4% | 13,602 | 64.4% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 90,617 | 44.5% | 80,739 | 44.3% | 9,878 | 46.6% | <0.001 | 19,672 | 46.6% | 9,837 | 46.6% | 9,835 | 46.6% | 0.98 |
| Yes | 113,007 | 55.5% | 101,672 | 55.7% | 11,335 | 53.4% | 22,580 | 53.4% | 11,289 | 53.4% | 11,291 | 53.4% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.95 | 1.60 | 0.95 | 1.61 | 0.88 | 1.54 | <0.001 | 0.87 | 1.53 | 0.87 | 1.52 | 0.87 | 1.53 | 0.87 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.